Inhalation Toxicology · 2009 · 89 citations · 22 references
Life SciencesImmunologyToxicologyCell SignalingInflammationNanomaterialsCell-nanoparticle InteractionsCytokine BiologyInflammatory SignalingMucosal InflammationNanomedicineNanotoxicologyAirway Epithelial ToxicityCellular Inflammatory ResponsesCytokine Mediator ReleaseCytokine Release AssaysInflammatory Responses To NanoparticlesPro-inflammatory Cytokine ExpressionPro-inflammatory Mediator ProductionTitanium Dioxide Nanoparticles
The initiation of an inflammatory process is the main adverse effect observed following the exposure of the airway epithelium to nanoparticles (NPs). This study was designed to explore the pro-inflammatory potential of two different NPs of similar size but of different compositions (CB 13 nm and TiO(2) 15 nm) on a human bronchial epithelial cell line (16HBE14o-). The expression of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL-6), and tumor necrosis factor alpha (TNFalpha) was evaluated in terms of mRNA, intracellular proteins, and released cytokines. Exposure to NPs induced a dose-dependent expression of all these cytokines, depending upon the chemical composition of NPs. The released cytokines appeared to be an inaccurate methodology to evaluate the pro-inflammatory response. Indeed, NPs adsorbed cytokines, and the binding was dependent on the nature of both the cytokine and NPs. Furthermore, addition of fetal calf serum or bovine serum albumin improved the detection of cytokines but also reduced cellular responses. Use of different detergents (Tween, Triton, and NP40) demonstrated limited efficiency to desorb cytokines from NPs. Thus, this study demonstrated the pro-inflammatory potential for CB and TiO(2) NP but underlines the methodological artifacts faced during the in vitro evaluation of cytokine release that necessitates a multiparametric evaluation.
22
In vitro toxicity of silica nanoparticles in human lung cancer cells
Weisheng Lin, Yue‐Wern Huang, Xiao‐Dong Zhou et al. · Toxicology and Applied Pharmacology · 2006 · 851 citations
Pharmacy, Oncology, Toxicology +15